2022 and Specialty Pharmacies - Pharmacy Technician Pulse

Dual GLP-1/GIP Receptor Agonist Shows Decreases in Hemoglobin A1c

Drug Topics

AUGUST 7, 2025

2 The current study, which was a 26-week, randomized, double-blind trial, was conducted at 5 sites in Mexico between February 2022 and February 2023 and included patients aged 18 to 75 years with a type 2 diabetes diagnosis for 6 or more months. Published 2022 Apr 5. Updated July 26, 2022. Diabetes Metab Syndr Obes.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Specialty Pharmacies Compounding Independent Pharmacies

FDA Approves Insulin Aspart-Xjhz as First Interchangeable Biosimilar to NovoLog

Drug Topics

JULY 21, 2025

Published 2022 Jun 20. doi:10.2147/DMSO.S342936 Newsletter Pharmacy practice is always changing. Orabone AW, Do V, Cohen E. Pharmacist-Managed Diabetes Programs: Improving Treatment Adherence and Patient Outcomes. Diabetes Metab Syndr Obes. 2022;15:1911-1923.

FDA

FDA Specialty Pharmacies Compounding Hospitals

Pneumococcal Vaccine Rates Low Despite Updated Recommendations

Drug Topics

JULY 11, 2025

In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. million adult patients who were enrolled in a health plan as of January 2022 that contributed data to the Optum database. Of those, 38% had evidence of pneumococcal vaccination prior to January 2022.

Vaccines

Vaccines Immunization Specialty Pharmacies Compounding

Financial Burden for Patients With Type 2 Diabetes Higher Than Those Without

Drug Topics

JULY 31, 2025

In 2022, the total estimated cost of diagnosed diabetes was $412.9 doi:10.1007/s13300-023-01505-2 Newsletter Pharmacy practice is always changing. 1 “Patients with diabetes were more likely to experience 2 of the 7 financial outcomes compared with 1.2 outcomes of patients without diabetes.” billion in the US, including $306.6

Specialty Pharmacies

Specialty Pharmacies Compounding Independent Pharmacies Immunization

Pharmacist Involvement Helps Reduce Time to A1c Target

Drug Topics

JUNE 13, 2025

In 2022, the estimated cost of those diagnosed as having diabetes was $413 billion. 2022 Jun 20;15:1911-1923. Additional advantages include fewer emergency visits, hospitalizations, medication adherence, and associated cost savings. 2 “Prevalence of diabetes in the United States continues to rise, affecting an estimated 38.4

Compounding

Compounding Specialty Pharmacies Independent Pharmacies Immunization

CGM Usage Improves Glycemic, Psychosocial Outcomes for Type 1 Diabetes | ADA 2025

Drug Topics

JUNE 23, 2025

Updated September 12, 2022. June 20 to 23, 2025. Chicago, Illinois. Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD). ClinicalTrials.gov identification: NCT04161131. Accessed June 23, 2025.

Compounding

Compounding Specialty Pharmacies Independent Pharmacies Immunization

Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End

Drug Topics

JULY 10, 2025

Daymon, 2022 Private Brand Intelligence Report, May 2023. Our team will be on site to share insights and showcase our portfolio of more than 500 health and wellness OTC products through the Foster & Thrive brand name, including affordable and eco-friendly offerings that reflect today’s consumer priorities. Fred Reichheld. April 2025.

Health and Personal Care Stores

Health and Personal Care Stores Independent Pharmacies Labelling Specialty Pharmacies

V116 Well-Tolerated With Broad Immune Responses in Pneumococcal Vaccine-Naïve Older Adults

Pharmacy Times

AUGUST 12, 2025

Pharmacy Times. Statistics Bureau of Japan Current population estimates as of October 1, 2022. FDA Approves V116 for Prevention of Invasive Pneumococcal Disease and Pneumonia. Published June 18, 2024. Accessed August 11, 2025. link] Accessed August 11, 2025. Haranaka M, Yono M, Kishino H, et al.

Immunization

Immunization Vaccines Compounding Pharmacies FDA

Pharmacist-Led Opioid Deprescribing Safe, Effective

Drug Topics

AUGUST 11, 2025

Researchers introduced a pharmacist-led opioid deprescribing campaign located within a specialty palliative care clinic. Developed and implemented by practicing pharmacists, the program ran from April 2022 to May 2023 and was conducted at a clinic seeing an average of 1100 patients every year. 2022 Dec 28;13:127-138.

Specialty Pharmacies

Specialty Pharmacies Labelling Compounding FDA

COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake

Pharmacy Times

JULY 25, 2025

According to 2022 data from a National Health Interview Survey of US adults ages 18 and older, just 23.0% Vaccination coverage among adults in the United States, National Health Interview Survey, 2022. Despite their purported efficacy and safety, uptake remains below target levels. Last Updated October 26, 2024. Accessed July 23, 2025.

Vaccines

Vaccines Compounding Pharmacies Immunization Compounding

FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks

Pharmacy Times

AUGUST 7, 2025

Expanded warnings include interactions with CNS depressants and rare outcomes like esophageal dysfunction, aligning with CDC's 2022 opioid prescribing guidelines. Labels now emphasize the risks of higher doses and caution against abrupt discontinuation in dependent patients to prevent withdrawal and other harms.

Labelling

Labelling FDA Compounding Pharmacies Vaccines

Rethinking Medication Adherence: Patient-Centered Solutions for Better Outcomes

Drug Topics

AUGUST 12, 2025

" To read these stories and more, download the PDF of the Total Pharmacy August issue here. April 5, 2022. References 1. Contributor: medication adherence is not a zero-sum game. Gualtieri L, Rosenbluth S. Can technology solve the problem of medication nonadherence? Mayo Clinical Proceedings: Digital Health. 2024;2(1):34-37.

Specialty Pharmacies

Specialty Pharmacies Immunization Mayo Clinic Compounding

The Changing Landscape of Pharmacy Accessibility

Pharmacy Times

JULY 22, 2025

Overall, community pharmacies have done an excellent job of providing accessibility to their patients, including physical access, convenience, cost savings, and catering to patients with diverse needs. 1 Unfortunately, the recent trend of pharmacy closures threatens equitable access to health care.

Mail-Order Pharmacies

Mail-Order Pharmacies Community Pharmacies Compounding Pharmacies Immunization

Antidiabetic Medication Combinations Have Varying Effects on Diabetic Kidney Disease Progression

Pharmacy Times

AUGUST 8, 2025

KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. 2022.06.008 Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Translating the A1C assay into estimated average glucose values. Kidney Int.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Pharmacies Hospitals Immunization

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Pharmacy Times

JULY 21, 2025

November 7, 2022. link] Download Issue PDF Download RIS Articles in this issue Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season Flu Vaccines Are a Go Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Vaccines

Vaccines Immunization Hospitals Compounding Pharmacies

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

Pharmacy Times

JUNE 9, 2025

Study Overview Researchers conducted a retrospective chart review of 80 patients aged 12 or older within Intermountain Health who were diagnosed with asthma between December 2022 and December 2023. To ensure continuity of care, patients included had seen a primary care provider both in the year prior to and following their diagnosis.

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Chemotherapy

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Pharmacy Times

JULY 12, 2025

December 2022. 2018.203609 Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. News release. Oregon Health and Science University. May 9, 2019. Accessed July 11, 2025. Arkansas Maternal Mortality Review Committee.

Independent Pharmacies

Independent Pharmacies Hospitals Compounding Pharmacies Immunization

Transitions of Care Pharmacists Mitigate Readmission Rates for COPD

Pharmacy Times

JUNE 23, 2025

Its average fiscal year 2022 readmission rate was 23.7%, exceeding the 19.6% 2 About the Author Huiqiao (Melinda) Fan, BSc, is a second-year PharmD candidate at the University of Connecticut School of Pharmacy in Storrs. HRRP benchmark.

Hospitals

Hospitals Compounding Pharmacies Vaccines Immunization

IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma

Pharmacy Times

JULY 8, 2025

Pharmacy Times. May 4, 2022. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Isatuximab shows promise in enhancing PFS for patients with multiple myeloma. August 8, 2024. Accessed July 8, 2025. Multiple myeloma.

Compounding Pharmacies

Compounding Pharmacies Immunization Specialty Pharmacies Compounding

Hypertension: A Silent Killer Requiring Novel Therapies

Pharmacy Times

JULY 19, 2025

Lancet 2022; 400:1927-1937. Cardiol and Therapy 2021;10:397-406. doi:10.1007/s40119-021-00233-7 Schlaich M, Bellet M, Weber M, et al. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial. Radner, PA: Idorsia Pharmaceuticals US, Inc; 2025 April.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Pharmacies Vaccines Immunization

Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback

Pharmacy Times

JULY 16, 2025

The trial was conducted from January 2021 to December 2022, with a feedback letter sent on or after January 2022, including physicians that were randomly assigned in a 4 to 1 allocation. The misuse and overuse of antimicrobials to treat, prevent, and control infections has influenced the spread of AMR.

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Specialty Pharmacies

A Review of Oral Cephalosporins for Common Outpatient Infections

Pharmacy Times

JULY 25, 2025

Updated September 21, 2022. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Arthritis Care Res ( Hoboken ). 2021;73(1):1-9. doi:10.1002/acr.24495. Gonococcal Infections Among Adolescents and Adults.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Department of Veterans Affairs Immunization Compounding Pharmacies

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

JUNE 23, 2025

In 2022, CMS reevaluated 505(b)(2) drugs in relation to section 1847A of the Social Security Act (SSA). In 2022, based upon a complaint filed by a pharmaceutical company, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said. This went into effect in January 2022.”

FDA

FDA Compounding Pharmacies Dosage Hospitals

Invest a Few Minutes in Inhaler Counseling

Pharmacy Times

JULY 23, 2025

link] 2022 global strategy for prevention, diagnosis, and management of COPD. Updated 2022. Lancet Respir Med.2022;10(5):447-458. 2022;10(5):447-458. doi:10.1016/S2213-2600(21)00511-7 Global strategy for asthma management and prevention. Accessed June 6,2025. Global Initiative for Asthma. Accessed June 6, 2025.

Hospitals

Hospitals Compounding Pharmacies Immunization FDA

Because Ned Said: New Technology Helps Prevent Opioid Overdose

Pharmacy Times

JUNE 9, 2025

September 28, 2022. In this study, participants experienced maximum concentration level reductions of up to 30% when exposed to higher buffer ingredient levels. It just might start saving lives. REFERENCES 1. The economic toll of the opioid crisis reached nearly $1.5 trillion in 2020. Joint Economic Committee. Accessed May 27, 2025.

Compounding Pharmacies

Compounding Pharmacies Compounding Immunization FDA

Zanubrutinib Linked to Lower Infection Risk Than Venetoclax Plus Obinutuzumab in Real-World CLL/SLL Study

Pharmacy Times

JULY 9, 2025

1,2 To better understand this relationship, researchers assessed 4754 patients with CLL/SLL who were treated with either venetoclax and obinutuzumab from April 2016 to August 2022 (n = 2104) or zanubrutinib from November 2019 to August 2023 (n = 2650).

Immunization

Immunization Compounding Pharmacies Hospitals Specialty Pharmacies

GLP-1s Lower Mortality, Neurodegeneration Risks

Drug Topics

JULY 25, 2025

Another notable detail from this study was that tirzepatide wasn’t FDA-approved until 2022, midway through the study period, possibly owing much of the GLP-1 benefits to semaglutide rather than tirzepatide.

Specialty Pharmacies

Specialty Pharmacies Compounding Independent Pharmacies Patient Care

Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr

Pharmacy Times

JULY 2, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding Pharmacies

Compounding Pharmacies FDA Immunization Specialty Pharmacies

Lipid-Lowering Effects Discovered in FDA-Approved Drugs Using Machine Learning

Pharmacy Times

AUGUST 9, 2025

prevalence of hypercholesterolemia and about a quarter of US adults harbored elevated low-density lipoprotein cholesterol (LDL-C) levels from 2017 to 2022. The American Heart Association’s 2023 Heart Disease and Stroke Statistics Update found a 34.7%

FDA

FDA Compounding Pharmacies Immunization Hospitals

New Online Competency Modules Standardize CPA Pharmacist Training at Academic Medical Center

Pharmacy Times

JUNE 9, 2025

link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review. Res Social Admin Pharm.

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Chemotherapy

Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice

Pharmacy Times

JULY 28, 2025

American Psychiatric Publishing; 2022. Cambridge University Press; 2013:129-236. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, text revision. Keepers GA, Fochtmann LJ, Anzia JM, et al. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.

Compounding Pharmacies

Compounding Pharmacies Compounding Insurance Immunization

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Pharmacy Times

JUNE 19, 2025

Source: Pharmaprojects, January 2024 Adoptive Cell Therapy: CAR T, TIL, and TCR Approaches Adoptive cell therapies (ACTs)—namely CAR T, tumor-infiltrating lymphocyte (TIL), and T-cell receptor (TCR) therapies—have seen fluctuating pipeline activity, peaking in 2022 and declining slightly since.

Compounding

Compounding Compounding Pharmacies FDA Immunization

Study Confirms Interchangeability of Hulio, Biosimilar of Humira, in Severe Chronic Plaque Psoriasis

Pharmacy Times

JUNE 24, 2025

Patients were enrolled from 31 sites across 4 countries between December 5, 2022, and September 19, 2023. Adalimumab received its initial approval from the FDA for the treatment of rheumatoid arthritis. 3 The trial’s primary objective was to evaluate the interchangeability of low-concentration Hulio (40 mg/0.8

Compounding Pharmacies

Compounding Pharmacies FDA Immunization Hospitals

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Pharmacy Times

JULY 10, 2025

Hillary Blackburn Pharmacy Focus Episode 40: Holistic Wellness for Oncology Patients Pharmacy Focus Episode 41: Medication Adherence Best Practices Pharmacy Focus Episode 42: Current Mental Health Treatment Needs Pharmacy Focus Episode 43: Financial Wellness FAQ with Tim Ulbrich BONUS: APhA 2022 feat.

Specialty Pharmacies

Specialty Pharmacies Vaccines Immunization Compounding Pharmacies

FDA Moves to Restrict 7-OH Opioid Products

Pharmacy Times

AUGUST 6, 2025

Published March 25, 2022. Reuters Staff. FDA recommends 7-OH compound found in vapes be controlled. link] Published July 29, 2025. National Institute on Drug Abuse. Accessed August 6, 2025. FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine. Food and Drug Administration. Published 2025.

FDA

FDA Controlled Substances Compounding Pharmacies Vaccines

Pharmacists' Guide to Selection and Use of At-Home Blood Pressure Monitors

Pharmacy Times

JULY 30, 2025

In 2022, HTN was cited as a primary or contributing cause of 685,875 deaths in the United States. According to the CDC, HTN is defined as consistent readings of systolic blood pressure greater than 130 mm Hg or a diastolic blood pressure greater than 80 mm Hg.1 1 According to CDC data, an estimated 48.1% million individuals.

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Compounding

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

Pharmacy Times

JUNE 17, 2025

OTC Use Saves Billions From Cost-Effective Products and Encounters Image credit: Amina | stock.adobe.com A 2022 publication purported $167 billion in savings in ancillary health care cost avoidance through the widespread use of OTC products in the United States. November 2022. REFERENCES The power of OTCs to provide consumer value.

Compounding Pharmacies

Compounding Pharmacies Drug Utilization Review Immunization Hospitals

ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide

Pharmacy Times

JUNE 23, 2025

1 Clinical Data for Tirzepatide Mechanism of Action Tirzepatide was approved by the FDA in May 2022 for adults with T2D to improve glycemic control, in conjunction with diet and exercise. Pharmacy Times Staff. Pharmacy Times. May 16, 2022. FDA Approves Tirzepatide Injection for Adults With Type 2 Diabetes.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization FDA

Ropeginterferon Alfa 2b Is Well-Tolerated, Efficacious in Treatment of Prefibrotic Myelofibrosis

Pharmacy Times

JUNE 30, 2025

Updated October 6, 2022. Pharmacy Times. Anemia (grade 1–2: n = 15, 21.1%; grade 3–4: n = 6, 8.5%), neutropenia (grade 1–2: n = 15, 21.1%; grade 3–4: n = 4, 5.6%) and thrombocytopenia (grade 1–2: n = 8, 11.2%; grade 3–4: n = 3, 4.2%) were the most common hematologic AEs. REFERENCES 1. Ropeginterferon alfa 2b for early myelofibrosis.

Compounding Pharmacies

Compounding Pharmacies Immunization Hospitals Compounding

Mitomycin Intravesical Solution Receives FDA Approval for Non-Muscle Invasive Bladder Cancer

Pharmacy Times

JUNE 12, 2025

November 16, 2022. Accessed June 12, 2025. Deng S, Meng F, Wang L, et al. Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis. Front Oncol. doi:10.3389/fonc.2022.1044830 2022.1044830 3. Prasad SM, Shishkov D, Mihaylov NV, et al.

FDA

FDA Compounding Pharmacies Vaccines Immunization

FDA Approves Biktarvy for Patients With HIV Previously Treated With Antiretroviral Therapy

Drug Topics

AUGUST 5, 2025

Updated March 2, 2022. Updated March 7, 2022. Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults. ClinicalTrials.gov identification: NCT02607930.

FDA

FDA Specialty Pharmacies Vaccines Compounding

Prescribing Cascades Can Often Lead to Polypharmacy for Older Adults

Drug Topics

JULY 30, 2025

Prescribing cascades can be appropriate when the combination has a positive benefit-risk balance, but if the ratio is negative, it would be inappropriate, explained authors in a separate study published in Deutsches Ärzteblatt International in 2022.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Specialty Pharmacies Independent Pharmacies Vaccines

Op-Ed: Celebrate Direct-to-Career Paths and Primary Care Pharmacy Practice

Pharmacy Times

JUNE 10, 2025

Accreditation Standards and Key Elements for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree. North American Pharmacist Licensure Examination Passing Rates for 2022-2024 Graduates. National Association of Boards of Pharmacy. July 1, 2024. Accessed June 6, 2025. January 21, 2025.

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Compounding

Psychiatric Medication Adherence in Patients Experiencing Homelessness

Pharmacy Times

JULY 17, 2025

Reviewing Medication Adherence According to the WeAllCount Census for 2022 to 2023, 6 homelessness in San Diego increased by 22% (from 8427 to 10,264 individuals).

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Hospitals Compounding Pharmacies Documentation

Dual GLP-1/GIP Receptor Agonist Shows Decreases in Hemoglobin A1c

FDA Approves Insulin Aspart-Xjhz as First Interchangeable Biosimilar to NovoLog

Trending Sources

Pneumococcal Vaccine Rates Low Despite Updated Recommendations

Financial Burden for Patients With Type 2 Diabetes Higher Than Those Without

Pharmacist Involvement Helps Reduce Time to A1c Target

CGM Usage Improves Glycemic, Psychosocial Outcomes for Type 1 Diabetes | ADA 2025

Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End

V116 Well-Tolerated With Broad Immune Responses in Pneumococcal Vaccine-Naïve Older Adults

Pharmacist-Led Opioid Deprescribing Safe, Effective

COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake

FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks

Rethinking Medication Adherence: Patient-Centered Solutions for Better Outcomes

The Changing Landscape of Pharmacy Accessibility

Antidiabetic Medication Combinations Have Varying Effects on Diabetic Kidney Disease Progression

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Transitions of Care Pharmacists Mitigate Readmission Rates for COPD

IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma

Hypertension: A Silent Killer Requiring Novel Therapies

Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback

A Review of Oral Cephalosporins for Common Outpatient Infections

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Invest a Few Minutes in Inhaler Counseling

Because Ned Said: New Technology Helps Prevent Opioid Overdose

Zanubrutinib Linked to Lower Infection Risk Than Venetoclax Plus Obinutuzumab in Real-World CLL/SLL Study

GLP-1s Lower Mortality, Neurodegeneration Risks

Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr

Lipid-Lowering Effects Discovered in FDA-Approved Drugs Using Machine Learning

New Online Competency Modules Standardize CPA Pharmacist Training at Academic Medical Center

Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Study Confirms Interchangeability of Hulio, Biosimilar of Humira, in Severe Chronic Plaque Psoriasis

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

FDA Moves to Restrict 7-OH Opioid Products

Pharmacists' Guide to Selection and Use of At-Home Blood Pressure Monitors

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide

Ropeginterferon Alfa 2b Is Well-Tolerated, Efficacious in Treatment of Prefibrotic Myelofibrosis

Mitomycin Intravesical Solution Receives FDA Approval for Non-Muscle Invasive Bladder Cancer

FDA Approves Biktarvy for Patients With HIV Previously Treated With Antiretroviral Therapy

Prescribing Cascades Can Often Lead to Polypharmacy for Older Adults

Op-Ed: Celebrate Direct-to-Career Paths and Primary Care Pharmacy Practice

Psychiatric Medication Adherence in Patients Experiencing Homelessness

Stay Connected